LYTIX BIOPHARMA AS

Home - Lytix Biopharma

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: ØR
Øystein Rekdal1962
Chairman of the board: MA
Marie Ann Roskrow1965
Years since formation: 22 years; since Aug 25, 2003
Type: Limited company
VAT registered: Yes
Number of employees: 6

Ownership

Number of shares and share classes: 68,159,434; 1 share class
Total number of shareholders: 1371; 280 companies, 1,091 persons

Financials

Total operating income 2023: 3,991,213; NOK
Annual total result 2023: -87,897,449; NOK
Total equity 2023: 51,319,307; NOK

Last update: May 14, 2025

Management

Management / administration

Name	Role	Shares
ØR Øystein Rekdal 1962	Managing Director/CEO	-

Board

Name	Role	Shares
BK Brynjar Kristian Forbergskog 1958	Board Member	3.27 % indirectly
KH Kjetil Hestdal 1960	Board Member	-
EW Evelina Wanda Matilda Vägesjö 1986	Board Member	-
HM Helena Marie-Louise Fjällskog 1964	Board Member	-
JM Jayson Michael Rieger 1975	Board Member	-
MA Marie Ann Roskrow 1965	Chairman	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
B BDO AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TA Terje Arnulf Johansen 1955	-	8.86 % directly 0.12 % indirectly 8.74 %
BK Brynjar Kristian Forbergskog 1958	Board Member	3.27 % indirectly
JF Jens-Otto Forbergskog 1987	-	2.41 % indirectly
YN Yngvar Nilssen 1986	-	2.04 % indirectly
ON Ole-Kristian Nergård 1992	-	2.03 % indirectly
PG Per Grieg 1957	-	1.92 % indirectly
BE Bernt Endrerud 1955	-	1.48 % indirectly
TH Tommy Hatteland 1990	-	1.44 % indirectly
SH Stig Hatteland 1980	-	1.44 % indirectly
ØH Øystein Hatteland 1992	-	1.44 % indirectly

Last update: Jun 10, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
J JAKOB HATTELAND HOLDING AS	NO0010405780	6,095,482	8.94 %
NC Na Citibank	NO0010405780	4,896,422	7.18 %
S SATURN INVEST AS	NO0010405780	4,485,579	6.58 %
T TAJ HOLDING AS	NO0010405780	4,455,566	6.54 %
EB Enskilda Banken Ab Skandinaviska	NO0010405780	2,500,000	3.67 %
L LYR INVEST AS	NO0010405780	2,438,863	3.58 %
B BRØDRENE KARLSEN HOLDING AS	NO0010405780	2,283,507	3.35 %
P PER STRAND EIENDOM AS	NO0010405780	2,019,102	2.96 %
3 3T PRODUKTER HOLDING AS	NO0010405780	1,808,764	2.65 %
L LYSNES INVEST AS	NO0010405780	1,448,987	2.13 %
Y YNNI INVEST AS	NO0010405780	1,392,889	2.04 %
H HIFO INVEST AS	NO0010405780	1,318,913	1.94 %
K KVASSHØGDI AS	NO0010405780	1,307,652	1.92 %
N NORDNET LIVSFORSIKRING AS	NO0010405780	1,195,351	1.75 %
C CARE HOLDING AS	NO0010405780	1,006,512	1.48 %
B BELVEDERE AS	NO0010405780	955,027	1.4 %
L LTH INVEST AS	NO0010405780	896,786	1.32 %
J JAHATT AS	NO0010405780	738,167	1.08 %
P PICASSO AS	NO0010405780	695,753	1.02 %
D DRAGESUND INVEST AS	NO0010405780	685,436	1.01 %
TB The Bank Of New York Mellon Sa/Nv	NO0010405780	609,353	0.89 %
J JPB AS	NO0010405780	590,839	0.87 %
N NORINNOVA INVEST AS	NO0010405780	557,510	0.82 %
BA Bank Ab Nordnet	NO0010405780	551,579	0.81 %
K KNUT FOSSE AS	NO0010405780	514,087	0.75 %
PO Per Ove Løkke Pettersen 1985	NO0010405780	510,000	0.75 %
H HOPEN INVEST AS	NO0010405780	481,117	0.71 %
H HARILA INVEST AS	NO0010405780	461,350	0.68 %
AV Arun Vohra 1974	NO0010405780	443,333	0.65 %
L LUKAS I AS	NO0010405780	395,000	0.58 %
S SPARLI AS	NO0010405780	394,597	0.58 %
KW Kai Wiggo Berger 1946	NO0010405780	387,917	0.57 %
N NEW LINK AS	NO0010405780	334,597	0.49 %
EB Erik Billington 1974	NO0010405780	333,333	0.49 %
H HERSETH AS	NO0010405780	300,000	0.44 %
BK Brynjar Kroknes 1961	NO0010405780	262,603	0.39 %
J JESEM AS	NO0010405780	250,000	0.37 %
H HUMAT AS	NO0010405780	227,301	0.33 %
P PROFOND AS	NO0010405780	224,324	0.33 %
K KREFTFORENINGEN	NO0010405780	218,000	0.32 %
S SALTHAVN AS	NO0010405780	211,111	0.31 %
T TRIM INVEST AS	NO0010405780	206,000	0.3 %
GØ Gunnar Øye 1965	NO0010405780	204,400	0.3 %
S STEIN TORE GUSTAVSEN AS	NO0010405780	203,008	0.3 %
F FREWI AS	NO0010405780	200,010	0.29 %
S SPIRALEN HOLDING AS	NO0010405780	200,000	0.29 %
D DR. RABIB HOLDING AS	NO0010405780	198,139	0.29 %
SI Securities Inc Bofa	NO0010405780	177,128	0.26 %
J JTT AS	NO0010405780	171,249	0.25 %
H HEYERN AS	NO0010405780	167,230	0.25 %
N NYHAMN AS	NO0010405780	166,666	0.24 %
F FM HOLDING AS	NO0010405780	166,666	0.24 %
ØR Øystein Rekdal 1962	NO0010405780	166,179	0.24 %
SA Switzerland Ag Ubs	NO0010405780	161,203	0.24 %
JE Jan Eyvin Wang 1956	NO0010405780	160,831	0.24 %
4 4 LB INVEST AS	NO0010405780	160,040	0.23 %
T TAVE INVEST AS	NO0010405780	156,488	0.23 %
N NORINNOVA AS	NO0010405780	155,790	0.23 %
P PHARMAPATENT AS	NO0010405780	152,420	0.22 %
A AGIR AS	NO0010405780	152,000	0.22 %
S SPAREBANK 1 NORD-NORGE PORTEFØLJE AS	NO0010405780	151,820	0.22 %
S SEAFOOD HOLDING AS	NO0010405780	150,000	0.22 %
E ENTREPRENØR-DIREKTØR'N HOLDING AS	NO0010405780	150,000	0.22 %
SC Stanley Co International Morgan	NO0010405780	146,206	0.21 %
A AMARONE HOLDING AS	NO0010405780	142,311	0.21 %
AE Alf Erik Damsgård 1958	NO0010405780	140,238	0.21 %
T TANANGER HOLDING AS	NO0010405780	140,000	0.21 %
C COUSI INVEST AS	NO0010405780	130,132	0.19 %
JF Jon Figenschou Eriksen 1946	NO0010405780	130,000	0.19 %
EB Enskilda Banken Ab Skandinaviska	NO0010405780	129,435	0.19 %
BA Bank Abp Nordea	NO0010405780	125,822	0.18 %
HF Hans Fredrik Bauck 1958	NO0010405780	125,000	0.18 %
ØM Øystein Magnus Albertsen 1956	NO0010405780	120,000	0.18 %
B BGB INVEST AS	NO0010405780	118,000	0.17 %
B BLOKMAR AS	NO0010405780	111,235	0.16 %
BA Bank Ab Avanza	NO0010405780	108,217	0.16 %
K KRÆMER AS	NO0010405780	108,000	0.16 %
M MIKINVEST AS	NO0010405780	106,545	0.16 %
Ø ØKSNES INVEST AS	NO0010405780	106,180	0.16 %
TI Torstein Ingvald Tvenge 1952	NO0010405780	100,000	0.15 %
E EIKESTAD AS	NO0010405780	100,000	0.15 %
E ELHATT AS	NO0010405780	100,000	0.15 %
S SØRLIA HOLDING AS	NO0010405780	100,000	0.15 %
M MEDIANORD AS	NO0010405780	96,250	0.14 %
TE Terje Eugen Aschim 1954	NO0010405780	96,000	0.14 %
O OMLAND INVESTMENTS AS	NO0010405780	93,866	0.14 %
KK Krzysztof Karol Staskiewicz 1980	NO0010405780	93,773	0.14 %
T TROMS KRAFT AS	NO0010405780	93,730	0.14 %
P POLARFJELLFLOKK AS	NO0010405780	93,112	0.14 %
B BYGGETUN EIENDOM AS	NO0010405780	91,551	0.13 %
E ETRADE ARCTIC AS	NO0010405780	91,190	0.13 %
AW Audun Wangensteen 1979	NO0010405780	90,000	0.13 %
M MOTOR TRADE EIENDOM OG FINANS AS	NO0010405780	84,966	0.12 %
TA Terje Arnulf Johansen 1955	NO0010405780	82,953	0.12 %
I ISTI AS	NO0010405780	80,000	0.12 %
B BAI AS	NO0010405780	75,000	0.11 %
H HØSE AS	NO0010405780	74,530	0.11 %
RØ Rune Ødegård Bjorbekk 1970	NO0010405780	70,000	0.1 %
MT Martin Tobias Orre 1976	NO0010405780	69,010	0.1 %
K KRANE AS	NO0010405780	67,860	0.1 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	3,991,213	17,273,000	25,827,000
Annual Total Result	-87,897,449	-56,007,000	-48,048,000
Total assets	63,874,065	152,017,000	202,962,000
Total liabilities	12,554,758	16,891,000	13,338,000
Total equity	51,319,307	135,126,000	189,624,000

P&L

Year	2023	2022	2021
Total operating income	3,991,213	17,273,000	25,827,000
Total operating costs	100,775,794	82,969,000	73,843,000
Operating result	-96,784,582	-65,696,000	-48,016,000
Financial income/costs	8,887,133	9,689,000	-32,000
Profit before tax	-87,897,449	-56,007,000	-48,048,000
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-87,897,449	-56,007,000	-48,048,000

Balance overview

Year	2023	2022	2021
Total fixed assets	548,491	124,000	0
Total current assets	63,325,574	151,893,000	202,962,000
Total assets	63,874,065	152,017,000	202,962,000
Short term debt	12,514,171	16,891,000	13,338,000
Long term debt	40,587	0	0
Total liabilities	12,554,758	16,891,000	13,338,000
Contributed capital	51,319,307	135,126,000	189,624,000
Retained earnings	0	0	0
Total equity	51,319,307	135,126,000	189,624,000
Total equity and liabilities	63,874,065	152,017,000	202,962,000

LYTIX BIOPHARMA AS985 889 635